ImageneBio, Inc. Common Stock (IMA)
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ImageneBio, Inc. Common Stock (IMA) is listed on Nasdaq, where it has traded since July 28, 2025.
- Listed On
- Nasdaq
- Listed Since
- July 28, 2025
- Employees
- 18
- Market Cap
- $48M
About ImageneBio, Inc. Common Stock
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 33 institutions reported holding IMA, with 6.2 million shares worth $36.8 million in aggregate. The largest reported holder was Bvf Inc/IL, with 1.1 million shares worth $6.5 million. Of the 5 largest holders listed below, 2 added shares, 1 reduced its position and 2 held their positions unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Bvf Inc/IL | 1,110,002 | $7M | Unchanged |
| Blue Owl Capital Holdings | 917,692 | $5M | Reduced 4.34% |
| Orbimed Advisors | 909,269 | $5M | Added 140.19% |
| Cable Car Capital | 781,599 | $5M | Added 3.56% |
| Omega Fund Management | 455,361 | $3M | Unchanged |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is IMA?
ImageneBio, Inc. Common Stock (IMA) is listed on Nasdaq, where it has traded since July 28, 2025.
Who are the largest institutional holders of IMA?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of IMA were Bvf Inc/IL, Blue Owl Capital Holdings and Orbimed Advisors.
How many institutions own IMA?
33 institutions reported a position in IMA for the quarter ended June 30, 2026, worth $36.8 million in total.
Did institutions buy or sell IMA last quarter?
Of the 5 largest reported holders, 2 added shares, 1 reduced its position and 2 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for IMA.
Every reported institutional holder, plus insider and congressional trades in IMA, on SentiSense.